Novartis AG Common Stock (NVS)
Stock-Based Compensation
$571.00M
TTM · Period ending: · USD
NVS Stock-Based Compensation
Latest reported$571.00Mperiod ending
Latest reported$571.00Mperiod ending
NVS TTM Stock-Based Comp ($0.00 → $571.00M)
TTM stock-based compensation
High-resolution chart · PNG
NVS stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 571,000,000 | |
| 838,000,000 | |
| 797,000,000 | |
| 1,069,000,000 | |
| 1,056,000,000 | |
| 1,046,000,000 | |
| 1,044,000,000 | |
| 772,000,000 | |
| 517,000,000 | |
| 482,000,000 | |
| 412,000,000 | |
| 609,000,000 | |
| 817,000,000 | |
| 799,000,000 | |
| 812,000,000 | |
| 810,000,000 | |
| 775,000,000 | |
| 756,000,000 | |
| 736,000,000 | |
| 700,000,000 | |
| 729,000,000 | |
| 743,000,000 | |
| 738,000,000 | |
| 749,000,000 | |
| 763,000,000 | |
| 738,000,000 | |
| 758,000,000 | |
| 783,000,000 | |
| 736,000,000 | |
| 717,000,000 | |
| 701,000,000 | |
| 946,000,000 | |
| 946,000,000 | |
| 791,000,000 | |
| 609,000,000 | |
| 1,015,000,000 | |
| 846,000,000 | |
| 846,000,000 | |
| 846,000,000 | |
| 903,000,000 | |
| 903,000,000 | |
| 903,000,000 | |
| 903,000,000 | |
| 1,007,000,000 | |
| 1,007,000,000 | |
| 1,007,000,000 | |
| 1,007,000,000 | |
| 892,000,000 | |
| 892,000,000 | |
| 892,000,000 | |
| 892,000,000 | |
| 1,000,000,000 | |
| 1,000,000,000 | |
| 1,000,000,000 | |
| 1,000,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |